Monitor for any filings from activist investors or significant ownership disclosures (Form 13D/G), as the extended poison pill suggests the board is preparing for potential takeover interest. The lack of financial impact means this is not a catalyst for immediate trading action.
Price Chart
Executive Summary
DMC Global Inc. (BOOM) filed a proxy supplement to extend the expiration date of its shareholder rights agreement (a 'poison pill') from June 2026 to June 2027. This defensive measure is designed to prevent any single investor or group from acquiring more than 10% (or 20% for passive investors) of the company's stock without board approval, protecting against hostile takeovers.
Key Financial Metrics
Key Facts
- The company extended the expiration date of its shareholder rights agreement from June 4, 2026, to June 4, 2027.
- The rights agreement acts as a poison pill, restricting any person or group from acquiring beneficial ownership of more than 10% of the outstanding common stock (20% for passive investors).
- This is a standard defensive corporate governance measure to deter hostile takeovers.
- The supplement was filed in conjunction with the 2026 annual shareholder meeting materials.
Financial Impact
No direct financial impact. The extension is a governance measure with no immediate effect on revenue, earnings, or cash flow.
Risk Factors
- The extension could signal that the board anticipates a potential takeover attempt, which might lead to future activist involvement.
- If a significant investor is already accumulating shares, this move could escalate into a proxy fight.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000034067-26-000030 |
| Document: 0000034067-26-000030-index-headers.html | 0000034067-26-000030 |
| Document: 0000034067-26-000030-index.html | 0000034067-26-000030 |
| Document: 0000034067-26-000030.txt | 0000034067-26-000030 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $6.12 | awaiting T+60 | — | $5.35 (−12.58%) |
Oct 27, 2026 today | Press Release | $5.74 | awaiting T+60 | — | $5.35 (−6.79%) |
Sep 22, 2026 5w ago | Institutional Cluster | $6.07 | awaiting T+60 | — | $5.35 (−11.86%) |
Apr 30, 2026 25w ago | Press Release | $8.41 $5.46 | ▲ +35.08% | ▲ +38.15% | $5.35 (+36.39%) |
Apr 27, 2026 26w ago | DEFA14A | $6.45 $6.60 | ▲ +2.33% | ▼ −2.45% | $5.35 (−17.05%) |
Apr 27, 2026 26w ago | 8-K | $6.45 $6.60 | ▲ +2.33% | ▼ −2.45% | $5.35 (−17.05%) |
Apr 24, 2026 26w ago | Press Release | $6.41 $6.40 | ▼ −0.16% | ▼ −5.24% | $5.35 (−16.54%) |
Mar 5, 2026 33w ago | 8-K | $5.43 $6.78 | ▲ +24.86% | ▲ +12.08% | $5.35 (−1.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers